個股熱度排行 | 6月6日港股收盤
根據uSMART輿情監測數據，6日港股交易時段，市場關注指數最高的5只股票是美團-W、理想汽車-W、比亞迪股份、藥明生物、廈門港務。
6月6日—港股關注排行TOP5
美團-W
關注度第一爲美團-W，該股今日收盤上漲9.93%，報於198.10港元。近5個交易日累計上漲20.87%。在消息面和社交媒體方面，輿情以看多爲主。較被市場關注的消息有：
美銀證券上調美團-W目標價至234元 評級「買入」
中金：維持美團-W“跑贏行業”評級 目標價上調11%至279港元
理想汽車-W
關注度第二爲理想汽車-W，該股今日收盤上漲12.40%，報於113.30港元。近5個交易日累計上漲19.83%。在消息面和社交媒體方面，輿情以看多爲主。較被市場關注的消息有：
恆生科技指數漲幅擴大至3%，理想汽車漲12%，美團漲近9%
恆生科技指數大漲1.75%，理想汽車漲近9%，美團漲超6%
比亞迪股份
關注度第三爲比亞迪股份，該股今日收盤上漲5.70%，報於300.60港元。近5個交易日累計上漲11.91%。在消息面和社交媒體方面，輿情以看多爲主。較被市場關注的消息有：
中信證券維持比亞迪462.9港元目標價 指其新車型訂單強勁
比亞迪股份AH股齊上揚 首5月累計銷量同比增長161.85%
藥明生物
關注度第四爲藥明生物，該股今日收盤上漲10.35%，報於62.90港元。近5個交易日累計上漲15.84%。在消息面和社交媒體方面，輿情以看多爲主。較被市場關注的消息有：
HSI Zooms Past 21,400; WUXI BIO Surges 10%
藥明生物漲超4.8% 全新生物製劑五廠已正式投入GMP生產
廈門港務
關注度第五爲廈門港務，該股今日收盤上漲46.90%，報於2.13港元。近5個交易日累計上漲70.40%。在消息面和社交媒體方面，輿情以看多爲主。較被市場關注的消息有：
廈門港務獲廈門港務投資溢價約55.17%提私有化 6月6日復牌
廈門港務復牌高開近47% 獲廈門港務投資溢價約55.17%提私有化
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app！
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
